Sigma Healthcare (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare (ASX: SIG)
    Latest News

    Five arrows hit the bullseye of five round targets lined up in a row, with a blue sky in the background.
    Opinions

    3 unstoppable ASX shares to buy with $3,000

    These investments have a very exciting future!

    Read more »

    Buy and sell keys on an Apple keyboard.
    Opinions

    Brokers say these 2 ASX shares are highly undervalued — here's why I agree

    I believe these ASX shares could deliver great returns.

    Read more »

    Excited couple celebrating success while looking at smartphone.
    Growth Shares

    Experts name 2 ASX growth shares to buy this week

    Let's find out which shares are being recommended for growth investors.

    Read more »

    A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
    Broker Notes

    Buy, hold, sell: Ventia, Sigma, and Mineral Resources shares

    What is Ord Minnett saying about these shares?

    Read more »

    Female pharmacist smiles with a digital tablet.
    Broker Notes

    3 reasons to buy Sigma Healthcare shares today

    A leading analyst expects “impressive growth” from Sigma Healthcare shares.

    Read more »

    A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
    Broker Notes

    Buy, hold, sell: ResMed, Sigma, and TechnologyOne shares

    Are analysts bullish on these popular stocks? Let's see what they are saying this week.

    Read more »

    Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
    Blue Chip Shares

    I'd buy these blue-chip ASX shares with $2,000 in a heartbeat

    With $2,000 to invest, I would focus on quality businesses that can keep growing rather than chasing short-term excitement.

    Read more »

    A young man punches the air in delight as he reacts to great news on his mobile phone.
    Growth Shares

    A rare buying opportunity in 1 of Australia's top shares?

    This company has a massive growth runway!

    Read more »

    Thumbs down Facebook icon over dark screen
    Broker Notes

    5 ASX 200 shares downgraded by experts this week

    Brokers lowered their ratings on Coles, Lottery Corporation and other stocks this week.

    Read more »

    Business people discussing project on digital tablet.
    Broker Notes

    What is Morgans saying about Flight Centre, Sigma, and Westpac shares?

    Are these big names buys, holds, or sells? Let's find out.

    Read more »

    A businessman in a suit adds a coin to a pink piggy bank sitting on his desk next to a pile of coins and a clock, indicating the power of compound interest over time.
    Growth Shares

    2 top ASX shares to buy and hold for the next decade

    These businesses have an incredible future, in my view.

    Read more »

    Girl with painted hands.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a miserable Tuesday for investors, and mortgage-owners.

    Read more »

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare

    Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The firm's activities include wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies, including the provision of retail support services to the branded network of pharmacy members, dose administration aid services, technology and data analytics solutions to the customers. The company was founded in 1912 and is headquartered in Clayton, Australia.

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    09 Jan 2026 Vikesh Ramsunder Issued 813,449 $2,350,867
    Issue of securities. 1824172 Rights
    09 Jan 2026 Danielle Di Pilla Issued 141,591 $409,197
    Issue of securities. 141,591 2025 LTI Rights
    09 Jan 2026 Mario Verrocchi Issued 314,021 $907,520
    Issue of securities. 314,021 2025 LTI Rights
    10 Nov 2025 Annette Carey Buy 10,000 $31,237
    On-market trade.
    28 Aug 2025 Jack Gance Sell 155,103,420 $480,820,602
    Off-market trade.
    29 May 2025 Danielle Di Pilla Sell 7,342,150 $23,312,794
    On-market trade.
    28 May 2025 Danielle Di Pilla Sell 7,500,000 $24,000,000
    On-market trade.
    27 May 2025 Danielle Di Pilla Sell 14,764,652 $46,609,053
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts has more than 40 years of experience in the medical device industry, including as the former Chief Executive Officer of Cochlear Limited from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. He is currently a non-executive director of HMC Capital Ltd (ASX:HMC). HMC Capital managed HealthcCo Healthcare and Wellness REIT (ASX:HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell has international healthcare and finance experience. He was Chief Financial Officer and Company Secretary at ASX-listed Cochlear Limited, a world leading medical device developer, manufacturer and seller of hearing devices. Mr Mitchell is currently the Chairman of ASX and NZX-listed Fisher&Paykel Healthcare Corporation (non-executive director from November 2018) and a non-executive director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He was formerly a non-executive director of ASX-listed Sirtex Healthcare, Osprey Medical Inc and Q'Biotics Group Limited. He has also performed roles with several industry and Government committees.
    Mr Michael Sammells Non-Executive DirectorNon-Executive Chairman Feb 2020
    Mr Sammells is also currently a non-executive director at AMP Limited and a director at GMBHA. He has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital development, mergers and acquisitions and IPOs. Further, Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder has experience in pharmacy retailing, wholesaling and logistics. He spent 28 years with the Clicks Group in South Africa. This included 18 years as part of the executive team. Before becoming Clicks Group Chief Executive Officer in January 2019, Mr Ramsunder held several roles within Clicks, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesale business, United Pharmaceutical Distributors from 2010.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is a current non-executive director of National Intermodal Corporation and a non-executive director of the Kinetic bus group. Prior to joining Sigma, Ms Carey has held director roles within the Linfox group of companies and has been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has previously held various senior roles within the Linfox Logistics group, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
    Mr Jack Gance Non-Executive Director Feb 2025
    Mr D Gance is a qualified pharmacist who joined MyChemist in 1998 and is currently the Chief Commercial Officer of Chemist Warehouse. Mr D Gance was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000.
    Ms Danielle Di Pilla Executive Director Feb 2025
    Ms Di Pilla is a qualified pharmacist who is currently the Chief People Officer at Chemist Warehouse. Ms Di Pilla established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla has been the managing director of DPP since it was incorporated. DPP is a wholly owned subsidiary of Chemist Warehouse. Ms Di Pilla also sits on the Board of Gotcha4Life.
    Mr Mario Verrocchi Executive Director Feb 2025
    Mr Verrocchi joined Jack and Sam Gance's pharmacy group in 1982. Mr Verrocchi established MyChemist with Jack Gance and Sam Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000. He is currently Chief Executive Officer of Chemist Warehouse.
    Mr Damien Gance Executive Director Feb 2025
    Mr J Gance as a pharmacist in 1967 and opened his first pharmacy store in Reservoir, Victoria, with Sam in 1972. In 1997, Mr J Gance, Sam Gance and Mario Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, Mr J Gance, along with Mr Sam Gance and Mr Verrocchi, established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr J Gance also created the brands Le Specs, Le Tan and Colours of Australis.
    Ms Kara McGowan General CounselCompany Secretary Oct 2021
    -
    Kara McGowan General CounselCompany Secretary
    -
    Mr M Conway Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 871,241,938 14.61%
    Citicorp Nominees Pty Limited 445,477,631 7.47%
    J P Morgan Nominees Australia Pty Limited 359,556,170 6.03%
    Dgsr Family Foundation Pty Ltd 353,829,615 5.93%
    Av Family Foundation Pty Ltd 313,784,873 5.26%
    Mjv Family Foundation Pty Ltd 313,784,873 5.26%
    Mr Sunil Narula 165,893,114 2.78%
    Bond Street Custodians Limited 150,545,209 2.52%
    Mat Family Foundation Pty Ltd 148,144,781 2.48%
    HMC Capital Partners Holdings Pty Ltd 103,399,008 1.73%
    Ms Nancy Fei Fei Jian 86,118,340 1.44%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 75,333,468 1.26%
    Mr Azman Rashid Haroon 64,502,845 1.08%
    Ms Danielle Di Pilla 61,243,218 1.03%
    Mr Claudio Avendano 55,986,398 0.94%
    Citicorp Nominees Pty Limited i 51,603,737 0.87%
    Bond Street Custodians Limited i 48,455,727 0.81%
    Di Pilla Investments Pty Ltd 44,228,054 0.74%
    Mr William Ho 41,669,145 0.70%
    Bond Street Custodians Limited ii 41,505,949 0.73%
    Mr Anthony Paul Bassaly 39,768,975 0.67%

    Profile

    since

    Note